Lawsuit accuses Gilead of propping up cost of lifesaving HIV treatments by blocking generic competition
May 14, 2019 at 18:11 PM EDT
The complaint names drugmakers Bristol-Myers Squibb and Johnson & Johnson subsidiary Janssen Pharmaceuticals as co-defendants.
